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Abstract Killer cell immunoglobulin-like receptors (KIR) are
the most polymorphic receptors of natural killer (NK) cells.
Their activity diversifies the functions of NK cells in the antiviral
immune response, so the presence of certain KIR may affect
transmission of HIV-1. The aim of the study was to evaluate
the influence of KIR genes on the susceptibility to HIV-1 infec-
tion in the Polish population depending on the route of exposure.
We determined the frequencies of activating (2DS1, 2DS2,
2DS3, 2DS4f, 2DS4del, 2DS5, 3DS1) and inhibitory (2DL1,
2DL2, 2DL3, 2DL5, 3DL1) KIRs in HIV-1-positive patients
(n=459), individuals exposed to HIV-1 but uninfected (EU,
n=118) and in uninfected, healthy blood donors (BD, n=98).
Analysis was performed using stepwise logistic regression.
Apart from KIRs, CCR5-Δ32, and CCR2-64I, alleles were also
analyzed, as we knew or suspected that these features could
affect susceptibility to HIV infection. The regression confirmed
the protective effect of CCR5-Δ32 (OR=0.25, p=0.006) and
CCR2-64I (OR = 0.59, p = 0.032) against HIV infection.
Among KIR genes, 2DL3 was found to be a protective factor
(OR=0.30, p=0.015). A similar effect was seen for 3DS1 but
only in intravenous drug users (IDUs) (OR=0.30, p=0.019),
not in sexually exposed people. 2DL5 was found to be a factor
facilitating HIV infection (OR=2.13, p=0.013). A similar effect
was observed for 2DL2 but only in females (OR= 2.15,
p=0.040), and 2DS1 in IDUs (OR=3.03, p=0.022). Our results
suggest a beneficial role of KIR3DS1 and 2DL3 supporting re-
sistance to HIV infection and a harmful effect of 2DS1, 2DL5,
and 2DL2 genes promoting HIVacquisition.
Keywords Susceptibility to HIV infection . Killer cell
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Host genetics
Introduction
The importance of host genetic factors in HIV infection has
been known for the last 20 years, from the role of the muta-
tions in genes encoding chemokines and their receptors, to
specific microRNA interfering with the virus replication cycle
(Arenzana-Seisdedos and Parmentier 2006; Farberov et al.
2015; Lama and Planelles 2007; O’Brien and Moore 2000;
Reynoso et al. 2014; Zwolińska 2009). The nature and mode
of action of these factors are very diverse. It includes the
prevention of HIV entry into the cells, as it is observed for
CCR5-Δ32 mutation (O’Brien and Moore 2000; Zwolińska
et al. 2013a), the modulation of the immune response against
virus, as it is shown in case of HLA and killer cell
immunoglobulin-like receptors (KIR) (Jennes et al. 2006,
2013; Martin et al. 2002), and finally the specific epigenetic
mechanisms of microRNA (Farberov et al. 2015; Reynoso
et al. 2014). The role of genetic features in HIV infection is
not always clear, and sometimes the results of research are
ambiguous or contradictory. This applies to the mutation in
chemokine receptors used as HIV co-receptors, e.g., CCR2-
64I (Ding et al. 2011; Zapata et al. 2013), human endogenous
retroviruses (Bhardwaj et al. 2014; van der Kuyl 2012;
Zwolińska 2006; Zwolińska et al. 2013b), and genes encoding
KIR, especially in the context of susceptibility to the virus
* Katarzyna Zwolińska
kjzwolinska@iitd.pan.wroc.pl
1 Laboratory of Virology, Ludwik Hirszfeld Institute of Immunology
and Experimental Therapy, Polish Academy of Sciences, Weigla 12,
53-114 Wroclaw, Poland
2 Department of Infectious Diseases, Liver Diseases and Acquired




(Hong et al. 2013; Paximadis et al. 2011; Tallon et al. 2014;
Tiemessen et al. 2011).
KIR are very polymorphic structures on natural killer (NK)
cells which are able to trigger their function due to passing
activating or inhibitory signals. Such regulation affects both
innate and adaptive immunity, particularly the antiviral re-
sponse. To date, 16 KIR genes, 601 alleles, more than 50
haplotypes, and 398 KIR genotypes have been identified
(González-Galarza et al. 2015; Takeshita et al. 2013).
Among them, there are seven genes encoding receptors trans-
mitting activating signals through the short cytoplasmic tail
(KIR2DS1, 2DS2, 2DS3, 2DS4, 2DS5A, 2DS5B, and 3DS1),
and eight genes encoding inhibitory receptors with long cyto-
plasmic tails (KIR2DL1, 2DL2, 2DL3, 2DL5A, 2DL5B, 3DL1,
3DL2, and 3DL3). KIR2DL4 may activate or inhibit NK cell
activity (Faure and Long 2002; González-Galarza et al. 2015).
Framework genes KIR3DL3, 2DL4, and 3DL2 and
pseudogene 3DP1 are present in almost all human genomes,
with rare exceptions (Niepiekło-Miniewska et al. 2014). KIR
genes are located in 15 different loci on chromosome 19q13.4,
and some of them are allelic variants, KIR3DL1/S1, 2DL2/
2DL3, and 2DS3/2DS5 (Jiang et al. 2012; Martin and
Carrington 2013). KIR haplotypes can possess from 7 to 12
genes and may be divided into two main haplotype groups A
and B on the basis of the presence of specific genes in centro-
meric and telomeric regions of the cluster. Centromeric A
(cenA) haplotype is characterized by the presence of
KIR2DL3 and the absence of 2DL2 and 2DS2. The last two
are determinants of centromeric B (cenB) haplotype.
Telomeric A (telA) haplotype is defined by the presence of
3DL1 and 2DS4 (both, full length or formwith 22-bp deletion,
2DS4del) and the absence of 2DS1. 2DS1 and 3DS1 are typ-
ified of telomeric B (telB) haplotype, where there is neither
2DS4 nor 3DL1 (Jiang et al. 2012). Some KIR alleles of one
gene may occupy different loci in centromeric or telomeric
regions (e.g., 2DS3/2DS5, 2DL5) (Jiang et al. 2012).
Haplotype A (cenA/telA) usually contains framework genes
plus KIR2DL1, 2DL3, 2DS4, and 3DL1 (Martin et al. 2000,
2004; Takeshita et al. 2013), and therefore activating signal
transmission by the KIR is limited, especially when KIR2DS4
has a 22-bp deletion (2DS4del) (Graef et al. 2009). Haplotype
B (cenA/telB; cenB/telA; cenB/telB) is more variable and has
more combinations of activating KIR (2DS1, 2DS2, 2DS3,
2DS5, and 3DS1) (Takeshita et al. 2013; Wilson et al. 2000).
Triggering activity of NK cells is associated with their recep-
tors’ variability and expression and also with the presence of
appropriate ligands, which are human leukocyte antigen
(HLA) class I molecules for killer immunoglobulin-like recep-
tors (Lanier 1998; Long and Rajagopalan 2000; Carrillo-
Bustamante et al. 2015).
Literature reports tend to focus on the contribution of KIRs
to AIDS progression rather than to susceptibility to HIV in-
fection. Most of the researchers emphasize the role of
KIR3DS1 and 3DL1 in AIDS development, in the presence
or absence of HLA-B Bw4-80I ligands (Gaudieri et al. 2005;
Jiang et al. 2013; Martin et al. 2002, 2007). KIR3DS1 was
indicated as a protective factor, in the context of resistance
to HIV during different ways of exposure (Boulet et al.
2008; Chavan et al. 2014; Habegger de Sorrentino et al.
2013; Tallon et al. 2014). Among KIR genes involved in sus-
ceptibility to HIV, KIR2DS4f was mentioned as an agent as-
sociated with accelerated HIV transmission to cohabiting se-
ronegative partners (Merino et al. 2011) and higher risk of
intrapartum transmission to children possessing KIR2DS4del
(Hong et al. 2013). KIR2DL3 with HLA-C1/C2 combination
was elevated in mothers transmitting HIV to their children
during delivery and was lower in infected children
(Paximadis et al. 2011). Some reports have indicated that
HIV transmission was influenced by the compatibility of sex-
ual partners for KIRs and HLA. Incompatibility between them
may oblige NK cells from the exposed partner to rejection of
incoming cells from the HIV-positive partner (Jennes et al.
2013). Also, presence of KIRs without their ligand, e.g.,
2DL2/2DL3 without HLA-C1 and 3DL1 without HLA-Bw4,
may inhibit HIV infection, as was observed in the exposed to
HIV but uninfected female sex workers in Côte d’Ivoire
(Jennes et al. 2006). Furthermore, it seems possible that peo-
ple with KIR genotypes with more activating genes (BB, AB)
and without ligands for inhibitory KIRs may be better
protected against HIV because of the effective NK activation
(Jennes et al. 2006, 2011). There has not been enough research
to uncover the effects of all KIR genes on HIV infection.
The main aim of the study was to evaluate the influence of
genes encoding KIR on susceptibility to HIV-1 infection via
the sexual route or intravenous drug injections. We deter-
mined the frequency of activating KIR2DS1, 2DS2, 2DS3,
2DS4f, 2DS4del, 2DS5, and 3DS1 and inhibitory KIR2DL1,
2DL2, 2DL3, 2DL5, and 3DL1 in the groups of exposed to
HIV and HIV-positive (HIV+) or uninfected (EU) people on
the background of the blood donors from Lower Silesia region
in Poland. During the preparation of the regression model for
describing the impact of KIRs on HIV infection, we could not
omit other well-known genetic factors (CCR5-Δ32, and
CCR2-64I); thus, they were included in the analysis. To our
knowledge, this is the first study in Poland describing the
contribution of KIR genes to susceptibility to HIV infection.
Patients and methods
PatientsWe included three groups of subjects in our study. The
first one (BD) consisted of 98 healthy, HIV-, HCV-, and HBV-
negative age-matched blood donors (40 women, 58 men) from
the Lower Silesia in Poland. Theywere used as a control ofKIR
gene frequencies in the studied population. The other two
groups comprised persons exposed to HIV but uninfected
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(EU, n=118) or infected with the virus (HIV+, n=459). The
exposure to HIV in each person in EU was long-lasting and
repeatable, and seronegativity was confirmed by standard lab-
oratory tests. Of them, 71.2 % were intravenous drug users
(EU-IDU; n=84) with on average 13.7 years history of addic-
tion (1.5 to 36 years); 89.3 % of them were HCV positive.
Sexually exposed, long-lasting partners of HIV-infected people
(EU-SE; n=34) were also included in the EU group. Similar
subgroups were distinguished among HIV-positive patients of
the Department of Infectious Diseases, Liver Diseases, and
Acquired Immune Deficiencies (Wroclaw Medical
University, Poland). We included in the HIV+ cohort 359 drug
addicts (HIV-IDU) and 100 sexually exposed people (HIV-SE).
These people were HIV positive and were selected on the basis
of a confirmed laboratory diagnosis. Both EU-IDU and HIV-
IDUwere also patients of Monitoring Laboratory for Infections
Among Drug Users in Wroclaw, Poland. The detailed charac-
teristics of HIV+ and EU groups are given in Table 1. All
procedures performed in studies involving human participants
were in accordance with the ethical standards of the institution-
al and/or national research committee and with the 1964
Helsinki declaration and its later amendments or comparable
ethical standards. Informed consent was obtained from all in-
dividual participants included in the study. The study was ap-
proved by the Commission of Bioethics at Wroclaw Medical
University (number of permission KB-182/2005).
Genotyping Genomic DNA was extracted from EDTA-
anticoagulated blood samples using a QIAamp DNA Blood
Midi Kit (Qiagen, Hilden, Germany). CCR5-Δ32 and CCR2-
64I alleles were determined as we described previously
(Zwolińska et al. 2013a). KIR genotyping was performed
using PCR-SSP according to our previous works
(Kuśnierczyk et al. 2015; Mozer-Lisewska et al. 2015). It
allowed us to detect the presence of KIR2DS1, 2DS2, 2DS3,
2DS4f, 2DS4del, 2DS5, 3DS1, 2DL1, 2DL2, 2DL3, 2DL5,
and 3DL1. We did not discriminate between centromeric and
telomeric 2DL5 and 2DS3/2DS5 forms.
Data analysis The presence of individual KIRs and KIR ge-
notypes (AA, Bx) was calculated as the percentage of posi-
tives among all people in the studied groups. Bx represented
both AB and BB genotypes, and it was characterized by the
presence of one or more of the following activating genes:
KIR2DS1, 2DS2, 2DS3, 2DS5, and 3DS1. AA genotype was
defined by the presence ofKIR2DS4 (the full version 2DS4f or
2DS4del) and absence of mentioned activating genes charac-
teristic for Bx. The differences in specific KIR and KIR geno-
type frequencies between BD, EU, and HIV+ groups were
evaluated using the χ2 test. Bonferroni correction was per-
formed in the case of multiple comparisons.
Linkage disequilibrium (LD) as a measure of associa-
tion of nonrandom alleles at two different loci was used to
assess the genetic association between KIR gene pairs in
studied groups. The strength of the association between the
two genes is dependent on D’ (LD) and r2 (relative linkage)
value. Their values range from 0 to 1, where 0 means in-
dependence between alleles and 1 reflects complete asso-
ciation between alleles at the two loci.
The evaluation of possible relations between studied KIRs
and susceptibility to HIV infection was performed in EU
(n=118) and HIV+ (n=459) groups, using stepwise logistic
regression in the generalized linear model scheme. The equa-
tion describing the probability of HIVacquisition during expo-
sure [P(y=1)] is as follows: P y ¼ 1ð Þ ¼ eβ1x1þβ2x2þ… þβnxnþβ0
1þeβ1x1þβ2x2þ… þβnxnþβ0 ,
where e is the base of the natural logarithm, x1, x2, and xn are
independent variables, n is the number of independent vari-
ables, β1, β2, and βn are regression coefficients indicating the
effect size of independent variables, and β0 is the intercept.
Presence of the studied feature in a given individual was
encoded as xn=1 and lack of it as xn=0. Odds ratio (OR) for,
e.g., variable x1, is defined by e
β1. We analyzed the impact of
the presence of KIR genes in the context of nongenetic factors,
such as sex and route of exposure to HIV (sexual and intrave-
nous drug use). We also analyzed presence of CCR5-Δ32 and
CCR2-64I, as we knew they could influence HIV infection and
we wanted to rule out the possibility of misinterpretation in our
results. Collinearity of the covariates was assessed with the
variance inflation factor (vif), and no collinearity was denoted
when vif <10.0. Akaike’s information criterion (AIC) was used
as a measure of fit of the models. Variables were included in the
model with p<0.05. All statistical analyses were performed
using the platform R-CRAN version 3.1.2 (www.r-project.org).
Results
Distribution of KIRs in the Polish population
of HIV-positive and HIV-negative people
The frequencies of 12 KIRs were evaluated in HIV-positive
and HIV-exposed but seronegative people (EU) and blood
donors (BD) from Lower Silesia in Poland. We also
showed the distribution of KIR genotypes AA (with the
only one activating KIR—2DS4) and genotypes with the
more varied KIR sets (Bx) (Table 2). No differences in
KIR frequencies between HIV+ patients and BD as well
as between EU and BD were detected (p > 0.05).
However, the comparison of presence of these features in
EU and HIV+ groups showed statistically significant dif-
ferences between frequencies of 2DL3 (95.76 vs. 83.88 %,
p= 0.010) and 2DL5 (34.75 vs. 53.16 %, p= 0.004). It may
suggest their opposite role in susceptibility to HIV infec-
tion—protective against virus acquisition for 2DL3 and
promoting infection for 2DL5. There were no statistically
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significant differences in genotypes AA and Bx between
groups (p> 0.05). Analysis of LD between tested KIRs in
HIV-positive, EU, and BD is shown in Table 3. It revealed
similarity between LD of some gene pairs in all groups
(e.g., high LD for KIR2DS2 and 2DL2). It also indicated
differences between groups, e.g., decreased LD for 2DS1
and 3DS1 in HIV+ and EU in comparison to background
population and reduced LD for pair 2DL3 and 2DL1 in
HIV+ individuals compared to EU and BD.
Effects of KIR and chemokine receptor genes
on susceptibility to HIV infection
We analyzed the effects of KIRs (Table 2) on susceptibility to
HIV infection by comparison of their distribution in EU and
HIV-positive people. Logistic regression was used for evalu-
ation of probability of HIV infection depending on KIR genes
in case of sexual exposure or intravenous drug use. We also
included in the model the presence of CCR5-Δ32 and CCR2-
Table 1 Baseline characteristics of the compared groups of people exposed to HIV, infected (HIV+), or seronegative (EU)
Group HIV+, n= 459 EU, n= 118
Feature Median Sn Q1 Q3 CI 95 % Median Sn Q1 Q3 CI 95 %
Age 29 6.1 25 36 28.4; 29.6 29 5.8 26 34 28.0; 31.0
Feature n % CI 95 % n % CI 95 %
Gender Women 153 33.3 29.0; 37.6 39 33.1 24.6; 41.5
Men 306 66.7 62.4; 71.0 79 66.9 58.5; 75.4
Sexual exposure (SE) Yes 100 21.8 18.0; 25.6 34 28.8 20.6; 37.0
No 359 78.2 84 71.2
Heterosexual exposure (HT) Yes 61 13.3 10.2; 16.4 32 27.1 19.1; 35.1
No 398 86.7 86 72.9
Homosexual exposure (HO) Yes 35 7.6 5.2; 10.1 2 1.7 0.0; 4.0
No 424 92.4 116 98.3
Homo/heterosexual exposure (HO/HT) Yes 4 0.9 0.0; 1.7 0 0.0 0.0; 0.0
No 455 99.1 118 100.0
Intravenous drug users (IDU) Yes 359 78.2 74.4; 82.0 84 71.2 63.0; 79.4
No 100 21.8 34 28.8
HCVa Yes 355 77.9 74.0; 81.7 77 68.1 59.6; 76.7
No 101 22.1 36 31.9
Sn - average dispersion, Q1, Q3 - 1st and 3rd quartiles, respectively, CI 95 % - 95 % confidence interval
a There were no data for HCV status for three individuals in HIV+ and five in EU group
Table 2 Frequencies of killer cell immunoglobulin-like receptor genes (KIR) and genotypes AA and Bx in studied groups
2DS1 2DS2 2DS3 2DS4f 2DS4del 2DS5 3DS1 2DL1 2DL2 2DL3 2DL5 3DL1 Genotypes AA Genotypes Bx
BD, n = 98 n 34 47 24 40 84 28 34 97 46 91 43 94 33 65
% 34.69 47.96 24.49 40.82 85.71 28.57 34.69 98.98 46.94 92.86 43.88 95.92 33.67 66.33
EU, n= 118 n 35 50 24 43 101 27 37 115 53 113 41 115 44 74
% 29.66 42.37 20.34 36.44 85.59 22.88 31.36 97.46 44.92 95.76 34.75 97.46 37.29 62.71
HIV+, n= 459 n 191 258 156 163 383 124 172 434 257 385 244 437 141 318
% 41.61 56.21 33.99 35.51 83.44 27.02 37.47 94.55 55.99 83.88 53.16 95.21 30.72 69.28
OR 1.69 1.75 2.02 0.96 0.85 1.25 1.31 0.45 1.56 0.23 2.13 0.52 1.34
CI 95 % 1.09 1.16 1.24 0.63 0.48 0.77 0.85 0.13 1.04 0.09 1.40 0.15 0.88
2.61 2.63 3.29 1.46 1.50 2.01 2.02 1.53 2.34 0.58 3.25 1.76 2.05
p* 0.213 0.087 0.052 1.000 1.000 1.000 1.000 1.000 0.378 0.010 0.004 1.000 0.173
BD - blood donors from Lower Silesia region of Poland, EU - exposed,HIV-1-seronegative,HIV + - exposed to HIVand seropositive, 2DS4f - full-length
KIR2DS4 gene, 2DS4del - KIR2DS4 with 22 base pair deletion, OR - odds ratio, based on the comparison of EU and HIV, CI 95% - 95 % confidence
interval, Bx - represents KIR genotypes AB and BB
*p value after Bonferroni correction (in case of comparison of KIRs frequencies)
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64I. They were analyzed to avoid misinterpretation of effects
of KIRs which could be caused by chemokine receptors
(O’Brien and Moore 2000; Zapata et al. 2013; Zwolińska et
al. 2013a). We did not find collinearity between variables
included to the model (vif <10.0, Table 4), so we could con-
sider their effects independently. We did not prove a link be-
tween KIR2DS2, 2DS3, 2DS4f, 2DS4del, 2DS5, 2DL3, 2DL5,
and 3DL1 with susceptibility to HIV infection. The genetic
factors involved in susceptibility to HIV infection are shown
in Table 4. Analysis confirmed a strong protective effect of
CCR5-Δ32 (p= 0.006), especially in females (p= 0.026).
CCR2-64I was also found to be a protective factor
(p=0.032). Among KIR genes, 2DL3was found to be a factor
reducing the risk of HIV infection (p=0.015) in contrast to
2DL5 (p=0.013), which was found to be an agent promoting
infection. The harmful role of 2DL2 was observed in women
(p=0.040) and 2DS1 in case of exposure to HIV via drug
injections (p=0.022). 3DS1 had a protective effect during
exposure to HIV among IDUs (p=0.019).
The presence of CCR5-Δ32mutation had the biggest effect
on HIV infection occurrence, as might have been expected.
This allele was present in 22.0 % of EU and 16.6 % of HIV+
people. Risk of infection in people who had this allele was
about four times lower (OR=0.25) than in people with the
wild version of the CCR5. This relation was even stronger in
women (βCCR5-Δ32:women=−1.212), resulting in more than 13
times lower risk of HIV infection among CCR5-Δ32 female
carriers (e−1.3982–1.2123=0.074). However, the beneficial influ-
ence of CCR5-Δ32was six times weaker in IDUs (OR=6.02)
than in SE people. Weaker than for CCR5-Δ32, but still a
protective effect against HIV infection was observed for
CCR2-64I. This allele was present in 28.8 % of EU and
22.2 % of HIV+ individuals. The CCR2-64I reduced the risk
of HIV infection by about 41 % (OR=0.59).
Logistic regression revealed that the presence of KIR2DL3
decreased the risk of HIV infection by about 70 %
(OR=0.30). The opposite effect was observed for 2DL5,
which increased this risk more twofold (OR= 2.13) and
2DL2, but only in women (OR=2.15).
A contradictory role of KIR2DS1 and 3DS1 on susceptibil-
ity to HIVon the intravenous drug use route was found. 2DS1-
positive drug addicts had three times higher risk of HIV infec-
tion (OR=3.03) than the negative ones had. On the other
hand, they had more than three times lower risk of infection
when they had the 3DS1 gene (OR=0.30).
Distribution of allelic versions of genes KIR2DL2/2DL3
and KIR3DL1/3DS1 in HIV-positive and HIV-negative
people
We analyzed the distribution of two pairs of KIR genes segre-
gated as alleles in HIV+, EU, and BD groups (KIR3DL1,
3DS1 andKIR2DL2, 2DL3 alleles) (Table 5). Every individual
had at least one of the 3DL1 or 3DS1 alleles. One of the EU
individuals (0.85 %) and 13 of HIV+ (2.83 %) had neither
2DL2 nor 2DL3. No differences in frequencies of combina-
tions 3DL1/3DS1, 3DL1 or 3DS1 alone as well as 2DL2/
2DL3, 2DL2 or 2DL3 alone between HIV+ patients and BD
as well as between EU and BDwere detected (p>0.05). 2DL2
without 2DL3 was detected in 3.39 % of the EU and in
13.29 % of the HIV+ group, which indicated the harmful role
of 2DL2 in case of exposure to HIV. 2DL2 presence with
absence of 2DL3 resulted in more than four times higher risk
of HIV acquisition (OR=4.37, p=0.005). A protective effect
Table 4 Role of studied genetic factors in susceptibility to HIV infection
Factors Impacta β OR CI 95 % p value vif
CCR5-Δ32 ↓ −1.398 0.25 0.09 0.68 0.006 3.394
CCR2-64I ↓ −0.531 0.59 0.36 0.96 0.032 1.040
KIR2DL3 ↓ −1.201 0.30 0.10 0.72 0.015 1.035
KIR2DL5 ↑ 0.757 2.13 1.19 3.96 0.013 1.873
KIR2DL2 in womenb ↑ 0.767 2.15 1.08 4.70 0.040 1.190
KIR2DS1 in IDUc ↑ 1.109 3.03 1.21 8.13 0.022 3.486
KIR3DS1 in IDUc ↓ −1.215 0.30 0.10 0.80 0.019 4.105
CCR5-Δ32 in IDUc ↑ 1.796 6.02 2.04 18.55 0.001 2.902
CCR5-Δ32 in womenb ↓ −1.212 0.30 0.10 0.86 0.026 1.860
Intercept – 2.297 – – – 6.88e-06 –
All data come from one regression model including all factors listed in the Table 3. There was no collinearity between the variables (vif < 10.0)
↑ - infection risk increased, ↓- infection risk reduced, β - coefficient in regressionmodel,CI 95-%95% confidence interval,OR - odds ratio, vif - variance
inflation factor, IDU - intravenous drug users
a Impact on susceptibility to HIV infection
b Compared with men
c Compared with individuals sexually exposed to HIV
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of the presence of 2DL3 without 2DL2 was indicated because
of overrepresentation in EU compared with HIV+ (54.24 vs.
41.18 %, respectively). Hence, it decreased the risk of HIV
infection by 41 % (OR=0.59, p=0.022). 2DL2/2DL3 hetero-
zygosity was almost equally represented in both groups
(Table 5).
Discussion
Our data highlights the impact of genes encoding KIR on the
risk of HIV infection in case of sexual exposure or intravenous
drug use. Presence of seven activating (2DS1, 2DS2, 2DS3,
2DS4f, 2DS4del, 2DS5, 3DS1) and five inhibitory (2DL1,
2DL2, 2DL3, 2DL5, 3DL1) KIRswas determined in the group
of HIV+, EU, and in healthy BD. The frequencies of KIRs in
the BD group did not differ significantly from those given by
the Allele Frequency Net Database for the Polish population
(González-Galarza et al. 2015).
The differences in some KIR frequencies in EU and HIV+
groups indicated their involvement in susceptibility to HIV
infections, e.g., KIR2DL3 and 2DL5 (Table 2). These differ-
ences prompted us to perform more comprehensive analysis
of the impact of KIRs on the risk of HIV infection depending
on the route of exposure. We also included in the analysis
alleles CCR5-Δ32 and CCR2-64I. Chemokine receptors are
used as main (CCR5) or alternative (CCR2, CCR3, CXCR4,
and other) co-receptors for HIV, and it is known that some of
their allelic versions may impact HIV infection (Arenzana-
Seisdedos and Parmentier 2006; O’Brien and Moore 2000;
Zwolińska 2009).
Logistic regression performed in our study revealed some
important relationships between tested genetic factors and sus-
ceptibility to HIV infection (Table 3). It was no surprise that
CCR5-Δ32 had a protective effect against HIVand decreased
infection risk about fourfold. There has been a lot of research
in recent years confirming restriction of HIV infection by this
allele (Hütter et al. 2009; Mahajan et al. 2010; O’Brien and
Moore 2000; Zapata et al. 2013; Zwolińska et al. 2013a and
references therein). Our analysis showed that the effect of
CCR5-Δ32 is particularly strong in females, but its favorable
impact is much lower in IDUs than in sexually exposed
CCR5-Δ32 carriers (Table 3). It may be associated with high
viral load during exposure by direct intravenous injections,
decreased immunity, and the poor general health condition
of drug addicts. In our previous work, based partially on the
same patients, we proved the beneficial role of CCR5-Δ32
during the heterosexual route of infection (Zwolińska et al.
2013a), but no effect was observed in the case of IDUs.
Most of the available data showed no effect of CCR2-64I
mutation on susceptibility to HIV infection (Mahajan et al.
2010; O’Brien and Moore 2000; Tan et al. 2010), indicating
rather its involvement in the slowing of AIDS progression
(Kaslow et al. 2005; O’Brien and Moore 2000; Vieira et al.
2011; Xu et al. 2010). However, there are some reports
supporting a protective role of CCR2-64I against vertical
HIV transmission (Mabuka et al. 2009) or via sexual exposure
(Zapata et al. 2013). Our present analysis showed a protective
effect of CCR2-64I against HIVacquisition. This allele result-
ed in a reduction of HIV infection risk by about 41 % regard-
less of the way of exposure (Table 3).
It is generally known that efficient activation of NK cells,
their cytolytic activity, and cytokine secretion is necessary for
anti-HIV reactions (Boulet et al. 2010; Jennes et al. 2006;
Martin and Carrington 2013; Tiemessen et al. 2011). That is
why KIR genotype AA may be harmful in the context of
exposure to HIV because of the limited possibility for NK cell
stimulation (only one activating gene, KIR2DS4, often defec-
tive 2DS4del, is present in AA genotype), whereas more di-
verse genotypes (BB or AB), with more activating genes or
Table 5 Frequencies of allelic
version of genes KIR3DL1/3DS1
and KIR2DL2/2DL3 in HIV-
positive and HIV-negative people
Groups 3DL1 3DL1/3DS1 3DS1 2DL2a 2DL2/2DL3a 2DL3a
BD, n = 98 n 64 30 4 7 39 52
% 65.31 30.61 4.08 7.14 39.80 53.06
EU, n= 118 n 81 34 3 4 49 64
% 68.65 28.81 2.54 3.39 41.52 54.24
HIV+, n= 459 n 287 150 22 61 196 189
% 62.53 32.68 4.79 13.29 42.70 41.18
OR 0.76 1.20 1.93 4.37 1.05 0.59
CI 95 % 0.49 0.77 0.57 1.56 0.70 0.39
1.17 1.87 6.56 12.27 1.58 0.89
p 0.436 0.844 0.569 0.005 1.636 0.022
p Value after Bonferroni correction
BD - blood donors from Lower Silesia region of Poland, EU - exposed, HIV-1-seronegative, HIV+ exposed to HIV
and seropositive, OR - odds ratio, based on the comparison of EU and HIV, CI 95% - 95 % confidence interval
a One of EU individuals (0.85 %) and 13 HIV+ individuals (2.83 %) had neither 2DL2 nor 2DL3
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any KIR genotypes but with no presence of ligands for inhib-
itory KIRs, should provide sufficient NK cell activation and
thus protection against HIV (Jennes et al. 2006, 2011). We did
not prove any beneficial effect of more varied genotypes of
KIRs, and there were no differences in genotypes AA or Bx
frequencies between EU and HIV+ people (Table 2). On the
other hand, O’Connell et al. suggested that strong NK cell-
mediated inhibition of viral replication was not absolutely
necessary for the immunological control of HIV in a group
of elite suppressors (ES) long-term controlling HIV viremia.
Some of their ES patients with A haplotype had stronger NK-
derived HIV inhibition than patients with haplotype B
(O’Connell et al. 2009). Moreover, Gaudieri et al. suggested
the association between haplotype B and faster CD4+ cell
count decrease leading to the progression of HIV infection
towards AIDS (Gaudieri et al. 2005). It might indicate that a
more diverse set of KIR on NK cells (haplotype B) makes
their activity regulation more difficult.
Our results allowed us to draw some unique conclusions
about specific KIR effects on susceptibility to HIV (Table 3).
Most of literature reports have focused onKIR3DS1 and 3DL1
and their effects on HIV infection course depending on the
presence of the ligand HLA-B Bw4-80I (Alter et al. 2007;
Gaudieri et al. 2005; Jiang et al. 2013; Martin et al. 2002,
2007). We found that the risk of HIV infection in individuals
with KIR3DS1 was more than three times lower in IDUs than
in SE people. KIR3DS1, especially when present on both
chromosomes, was indicated as a protective factor during dif-
ferent ways of infection (Boulet et al. 2008; Chavan et al.
2014; Habegger de Sorrentino et al. 2013; Tallon et al.
2014). Our results are particularly consistent with the work
of the group of Tallon, who demonstrated that the time of
seroconversion in long-term repeatedly HIV-exposed people
was significantly longer in homozygotes KIR3DS1/3DS1 than
heterozygotes KIR3DS1/3DL1. This situation occurred only
among injection drug users, not in the case of initially HIV-
negative partners of serodiscordant couples (Tallon et al.
2014). Mechanisms of positive action of KIR3DS1 in anti-
HIV action are still unknown. Most explanations assume the
effective activation of NK cells against HIV proteins via
KIR3DS1 interaction with its putative ligand HLA-B Bw4-
80I. It still remains controversial because there is no evidence
that HLA-B Bw4-80I, a well-known ligand of inhibitory
KIR3DL1, may also serve as a functional ligand for
KIR3DS1 (Martin and Carrington 2013; Martin et al. 2002,
2007; Tallon et al. 2014). Moreover, it seems that the activa-
tion of NK cells via KIR3DS1 and 3DL1 is dependent onwhat
was presented by their peptide ligands, as it was shown by
O’Connor et al. (2015).
Our findings indicated that the positive effects of
KIR3DS1 among drug addicts were diminished by the
presence of KIR2DS1. KIR2DS1-positive IDUs had more
than three times higher risk of HIV acquisition than did SE
individuals. To date, there has been no report about
KIR2DS1 contribution to HIV infection. Both KIR3DS1
and 2SD1 trigger NK cell function into their activation,
but it occurs after binding different ligands. KIR2DS1
binds HLA-C2 (Lys80), but with low affinity, and its
high-affinity ligand is not known (Martin and Carrington
2013). It is possible that expression of KIR2DS1 on NK
cells does not provide their sufficient activation against
HIV. Both 2DS1 and 3DS1 genes (characteristic for
telomeric B haplotype) are in almost perfect LD in our
BD group (D’= 0.910; r2 = 0.828), what is concordant with
the data for Polish population (González-Galarza et al.
2015). Is interesting to note that LD for this pair is de-
creased in EU and HIV+ individuals (see Table 3). 2DS1
is overrepresented in HIV+. Both groups are enriched for
haplotypes with 2DS1 but without 3DS1 (5.1 % for EU and
7.0 for HIV+), and, in the EU group, there are more hap-
lotypes with 3DS1 but without 2DS1 than in the HIV+ one
(6.8 vs. 2.8 %, respectively).
Another interesting finding was associated with KIR2DL2,
2DL3, and 2DL5 (Table 4). We detected the protective effect
of 2DL3 against HIVacquisition and the harmful role of 2DL5
and 2DL2 but only in females. Both 2DL2 and 2DL3 recep-
tors bind to HLA-C1 (Asn80) and transfer an inhibitory signal
to NK cells, but 2DL2 has higher affinity to its ligand than
2DL3 (Frazier et al. 2013). The ligand for 2DL5 has not been
identified yet (Martin and Carrington 2013). Our results are
not in line with investigations by Jennes et al. (2006, 2013)
and Paximadis et al. (2011). Jennes et al. (2006) reported
significantly higher frequencies of KIR2DL2 and 2DL5 in a
group of HIV-exposed but seronegative (ESN) than in HIV-
seropositive (SP) female sex workers.KIR2DL2/2DL3 hetero-
zygotes were more frequent in the ESN (62 %) than in the SP
(25%) individuals. The opposite situation was seen in the case
of homozygous 2DL3, which was present in 14% of ESN and
60 % of SP individuals. Furthermore, HIV restriction was
observed in ESN subjects who were carriers of inhibitory
KIR2DL2/2DL3 but not their ligand, HLA-C1. KIR2DL3/
2DL3 homozygotes with HLA-C1 were characteristic for
HIV-seropositive female sex workers (Jennes et al. 2006),
which could be due to NK cell inhibition. Paximadis and co-
workers (2011) reported an increased frequency of homozy-
gosity of KIR2DL3 alone and in combination with HLA-C1/
C2 in mothers transmitting HIV to their children perinatally
(TR) compared with mothers who did not transmit the virus
(NT). On the other hand, TR had a lower frequency of the
heterozygous combination KIR2DL2/2DL3 than NT, suggest-
ing its protective role of 2DL2 against HIV perinatal transmis-
sion to the children. Paximadis et al. (2011) reported that
KIR2DL3 in combination with HLA-C1 and homozygosity
for KIR2DL3 with HLAC1/C2 were both lower in infected
children (INF) compared to EU children. This corresponds
with our results indicating the anti-HIVeffect of KIR2DL3.
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The impact of studied KIR on the susceptibility to HIV in
our groups may be associated with specific KIR haplotypes.
KIR2DL3 is a part of centromeric haplotype A, so its protec-
tive character could be also mediated by 2DL1 from this hap-
lotype. However, 2DL1 may be also located in centromeric B
haplotypes, together with 2DL5B and 2DL2. Our genotyping
system did not allow for discrimination between centromeric
2DL5B and telomeric 2DL5A, and we could not determine
which version was responsible for the unbeneficial effect on
susceptibility to HIV. The impact of 2DL5B could be also
associated with 2DL1 and 2DL2, and we showed harmful
action of 2DL2 in the case of a woman. High positive LD
between 2DL2 and 2DS2 in HIV+ and EU (see Table 3) sug-
gested a similar role for both these genes, but we have not
proven it in the regression analysis. Contribution of 2DL1
seems to be unclear due to the possibility of its location in
both centromeric A and B regions. Hilton et al. showed that
2DL1 encoded by centromeric A alleles binds his ligands
HLA-C2 with greater avidity than 2DL1 on the centromeric
B part (Hilton et al. 2015). If the negative effect of 2DL5 is
associated with telomeric B alleles, it may be also related with
2DS1, the harmful role of which we showed in the IDU group.
However, haplotypic association with susceptibility to HIV
demands further clarification.
There is no doubt that NK cells are very important in im-
munity and that KIR are responsible for modulation of NK
cells’ anti-HIV activity. However, it is quite difficult to draw
general conclusions about the impact of specific KIRs on sus-
ceptibility and the course of HIV infection. Such analysis is
specifically difficult because of the high diversity of these
genes and because of HIV variability and its defensive strate-
gies. Certainly, specific KIR genes may be present in many
combinations as one of the 398 KIR genotypes identified or
others not discovered yet (González-Galarza et al. 2015;
Takeshita et al. 2013). Furthermore, they are very polymor-
phic; e.g., the most polymorphic KIR3DL1/3DS1 locus has
more than 70 inhibitory and more than 15 activating alleles
(Robinson et al. 2013). Some alleles may be expressed at
different levels; e.g., KIR3DL1 can be expressed at a high
(allele 3DL1*h) or low level (allele 3DL1*l) or even is absent
on the cell surface because of internalization in the cytoplasm
(allele 3DL1*004) (Martin et al. 2007). The expression of
KIRs on the NK surface is highly varied, and two individuals
may have different KIR panels on their NK, despite having the
same KIR gene repertoire (Gardiner 2008). Besides that, the
strength of NK activation or inhibition is associated with re-
ceptor–ligand relations, and even different alleles of the same
genemay bind their ligands with different avidity (Hilton et al.
2015). Moreover, the activity of NK cells is dependent not
only on the balance of activating/inhibitory signaling derived
from KIRs but also on other receptors, e.g., NKG2, which
were also found to be an HIV restriction factor (Fogli et al.
2008). The diversity in genes encoding NK cell receptors,
including in different geographic populations and complexity
of NK reactions during HIV infection, is probably the reason
for the inconsistent or divergent results of research in this
field.
This work supports the beneficial role of activating
KIR3DS1 and inhibitory 2DL3 and the unfavorable effect of
activating 2DS1, inhibitory 2DL5, and 2DL2 genes in resis-
tance to HIV infection. These findings are original and unique.
According to our knowledge, this study for the first time takes
into consideration the impact of KIR genes on susceptibility to
HIV in the Poland population. Because of this, this work has
some limitations, such as the relatively small study groups and
the impossibility to compare our results with other analyses in
the Polish general population. Moreover, we plan to extend
our research on the impact of KIR and their HLA ligand com-
binations as well as on high-resolution KIR genotyping with
regard to alleles with high and low expression on the NK cell
surface, which requires further investigations.
In summary:
1. CCR5-Δ32 and CCR2-64I alleles protected against HIV
infection.
2. KIR2DL3 was found to be a protective factor and
KIR2DL5 as a factor promoting HIV infection.
3. KIR3DS1 decreased and KIR2DS1 increased the risk of
HIV infection during intravenous drug injection but not
via sexual exposure.
4. KIR2DL2 was found to be a factor increasing the risk of
HIV infection in females.
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